Nutritional supplementary food formed of packaged part of citric acid and sodium bicarbonate

Abstract

To avoid as possible foam formation before use, pass raw materials through a filling machine used in production of nutritional supplementary food, and allow a consumer to find that foam formation is preferably achieved in use.SOLUTION: There is provided nutritional supplementary food obtained by separating sodium bicarbonate and citric acid and packaging each of them. In a package in which the sodium bicarbonate is packaged, a raw material including no acid is blended. The citric acid is a citric acid which is coated with calcium. The sodium bicarbonate is a grain product. In the package including the citric acid, grain products of isomalt, are added. Into the package including the sodium bicarbonate, indigestible dextrin is put. Into the package including the sodium bicarbonate, grains of the indigestible dextrin, lemon being a flavor, xylitol, and stevia being a sweetener are put. In the package including the citric acid, grain products of isomalt are added.SELECTED DRAWING: Figure 9

Description

[Technical field]

[0001] The present invention relates to a dietary supplement comprising packets of baking soda and citric acid. [Background technology]

[0002] It has been known that carbonated water can be produced by mixing baking soda, citric acid, and water.

[0003] Patent Document 1 discloses a tablet containing citric acid and sodium bicarbonate, which is in tablet form and contains citric acid and sodium bicarbonate as main ingredients, as well as a binder such as PEG, a dispersant, a lubricant, and a flow agent, and which is characterized in that the hydrogen ions and bicarbonate ions generated when the tablet is dissolved in water are absorbed into the body fluids, thereby achieving the acid-base balance of the body fluids and contributing to the maintenance of homeostasis in the internal environment of the body. The tablet is in tablet form and contains citric acid and sodium bicarbonate as main ingredients, as well as binders such as PEG, dispersants, lubricants, and flow agents. The hydrogen ions and bicarbonate ions generated when the tablet is dissolved in water during bathing, face washing, hair washing, etc. are absorbed into the body fluids, thereby improving the acid-base balance of the body fluids, contributing to cell activation in the body, promoting metabolism, and contributing to maintaining homeostasis of the internal environment of the body by participating in the citric acid cycle. The tablet form contains citric acid and sodium bicarbonate as main ingredients, and also contains binders such as PEG, dispersants, lubricants, and flow agents. The tablet contains citric acid and sodium bicarbonate, and is characterized by the fact that it exhibits a synergistic effect with medicines, supplements, cosmetics, food, drinking water, etc. by utilizing the long-term supply of hydrogen ions and bicarbonate ions that are generated when the tablet is dissolved in water. The present invention discloses a tablet containing citric acid and sodium bicarbonate, which is in tablet form and contains citric acid and sodium bicarbonate as main ingredients, as well as a binder such as PEG, a dispersant, a lubricant, and a flow agent, and which is characterized in that by continuously applying the tablet to a local area of ​​the body, bicarbonate ions generated from the tablet containing citric acid and sodium bicarbonate are absorbed into the local area, thereby contributing to the maintenance of homeostasis of the local environment within the body. The tablet is in tablet form and contains citric acid and sodium bicarbonate as main ingredients, as well as binders such as PEG, dispersants, lubricants, and flow agents. When the tablet is dissolved in hot water during bathing, etc., sodium ions slowly dissolve and react with citric acid to produce sodium citrate, which softens the skin surface. The slowly dissolving hydrogen ions and bicarbonate ions are absorbed into the skin, contributing to the maintenance of homeostasis in the internal environment of the body. The tablet form contains citric acid and sodium bicarbonate as main ingredients, and also contains binders such as PEG, dispersants, lubricants, and flow agents. The tablet is characterized in that the remaining hot water containing hydrogen ions and bicarbonate ions generated when the tablet is dissolved in water during bathing, washing face, washing hair, etc., is used as supplementary water for laundry and supplementary water for the growth of plants such as trees and vegetables. The tablet-shaped tablet is made up of citric acid and sodium bicarbonate as main ingredients, and contains binders such as PEG, dispersants, lubricants, and flow agents. The hydrogen ionized water that is generated when the tablet is dissolved in water and does not contain impurities is used as auxiliary water for cleaning various items and auxiliary water for burning fossil fuels. The tablet form contains citric acid and sodium bicarbonate as main ingredients, and also contains a binder such as PEG, a dispersant, a lubricant, and a flow agent. The tablet contains citric acid and sodium bicarbonate, and is characterized in that the concentration of carbon dioxide gas generated when the tablet is dissolved in water is increased by dissolving the tablet in water with a water-soluble agent or gel of pH 5 to 6.5 as an auxiliary, thereby exerting the effect of promoting blood flow by dilating the blood vessels in the body. The present invention discloses a tablet containing citric acid and sodium bicarbonate according to any one of claims 1 to 8, characterized in that the weight ratio of citric acid:sodium bicarbonate is 1:3-6. A method for producing tablets containing citric acid and sodium bicarbonate is disclosed, which is characterized by mixing anhydrous citric acid powder and sodium bicarbonate powder as the main ingredients with binders, dispersants, and lubricants such as PEG as auxiliary agents, and compressing the mixture into tablets. A method for producing tablets containing citric acid and sodium bicarbonate is disclosed, which comprises adding and mixing anhydrous citric acid and a portion of anhydrous silicic acid, which is a lubricant and a flow agent, to improve fluidity, mixing sodium bicarbonate into the raw material, adding polyethylene glycol 6000, a small amount of sucrose fatty acid ester, which is a lubricant, and PVP, which is a solubilizing agent and binder, and compressing the mixture into tablets. The method for producing a tablet containing citric acid and sodium bicarbonate according to claim 11 is disclosed, characterized in that the weight ratio of anhydrous citric acid:sodium bicarbonate is 1:3-6. A cosmetic material containing a high concentration of bicarbonate ions is disclosed, which is characterized by comprising: a first cosmetic material consisting of a gel containing citric acid as the main component with small amounts of fragrances consisting of peppermint, olive oil, etc.; and a second cosmetic material consisting of a face mask impregnated with a high concentration of HCO3-. A beauty method using a cosmetic material containing a high concentration of bicarbonate ions is disclosed, which includes the steps of applying a first cosmetic material consisting of a gel containing citric acid as the main ingredient with small amounts of fragrances such as peppermint and olive oil to the face and leaving it for 1 to 3 minutes, and attaching a second cosmetic material consisting of a face mask impregnated with a high concentration of HCO3- to the face, generating a large amount of bubbles and generating a high concentration of HCO3- through the gradual decay of the bubbles over time, thereby promoting the beauty effects of the face.

[0004] Patent Document 2 discloses a method for producing tablets in which a mechanical fluidized bed granulator that does not substantially use air for agitation is used to raise the powder temperature of a mixture of citric acid and polyethylene glycol to 60-65°C and cool to obtain granulated material A, and a mixture of sodium bicarbonate and polyethylene glycol also heated to 60-65°C and cooled to obtain granulated material B, which is mixed in a ratio of 1:2 to 1:10 and compression molded. The present disclosure discloses a method for producing tablets, which involves using a mechanical fluidized bed granulator that does not substantially use air as an agitating agent to raise the powder temperature of a mixture of citric acid and polyethylene glycol to 60-65°C, cooling the mixture to obtain granulated material A, and similarly raising the powder temperature of a mixture of sodium bicarbonate and polyethylene glycol to 60-65°C and cooling the mixture to obtain granulated material B, which is mixed in a ratio of 1:4 to 1:6 and compression molded. The present disclosure discloses a method for producing tablets, which involves using a mechanical fluidized bed granulator that does not substantially use air as an agitating agent to add ethanol to a mixture of citric acid and polyethylene glycol, raise the powder temperature to 60-65°C, and cool to obtain granulated material A, and similarly adding ethanol to a mixture of sodium bicarbonate and polyethylene glycol, raising the powder temperature to 60-65°C, and cooling to obtain granulated material B, which is mixed in a ratio of 1:2 to 1:10 and compression molded.

[0005] Patent Document 3 discloses a method for managing the water-electrolyte metabolism of a living body and the acid-base balance in the blood, which is characterized by continuously administering an injection containing 130-145 mEq / L of sodium ion, 2-5 mEq / L of potassium ion, 20-35 mEq / L of bicarbonate ion, 90-130 mEq / L of chloride ion, 2-5 mEq / L of calcium ion, 0.5-2.5 mEq / L of magnesium ion, 1-7 mEq / L of citrate ion, and 0-5 g / L of glucose at a rate of 2-60 mL / Kg / hr. A method for controlling the water / electrolyte metabolism and blood acid-base balance of a living body is disclosed, which is characterized by changing the administration rate or terminating administration using measurements obtained from blood gas analysis as an index. The method disclosed is characterized in that the administration rate is adjusted for the purpose of maintaining the blood HCO3- concentration within the range of 22 to 26 mEq / L. The method is disclosed for controlling the water-electrolyte metabolism and blood acid-base balance of patients complicated with metabolic acidosis. The method is disclosed for controlling the water-electrolyte metabolism and blood acid-base balance of a febrile patient. The method for controlling the water-electrolyte metabolism and blood acid-base balance of a patient in hemorrhagic shock is disclosed. The method for controlling the water-electrolyte metabolism and blood acid-base balance of a patient with multiple organ failure is disclosed. Said method for controlling water-electrolyte metabolism and blood acid-base balance in patients with systemic inflammatory response is disclosed. Said method for controlling the water-electrolyte metabolism and blood acid-base balance of a surgical patient is disclosed. The method is disclosed for controlling water-electrolyte metabolism and blood acid-base balance in a patient suffering from dehydration. Disclosed is an agent for controlling water-electrolyte metabolism in a living body and acid-base balance in blood, which contains 130-145 mEq / L of sodium ions, 2-5 mEq / L of potassium ions, 20-35 mEq / L of bicarbonate ions, 90-130 mEq / L of chloride ions, 2-5 mEq / L of calcium ions, 0.5-2.5 mEq / L of magnesium ions, 1-7 mEq / L of citrate ions, and 0-5 g / L of glucose. A biological water-electrolyte metabolism and blood acid-base balance control agent is disclosed for adjusting the administration rate to 2-60mL / Kg / hr with the goal of maintaining the blood HCO3- concentration within the range of 22-26mEq / L. Disclosed is an agent for controlling water electrolyte metabolism in a living body and acid-base balance in blood, characterized in that the source of citrate ions is sodium citrate and the pH is adjusted to 6.5 to 7.4 with carbon dioxide gas. Disclosed is an agent for controlling water / electrolyte metabolism and acid-base balance in a living body, which is characterized by being filled in a carbon dioxide gas-permeable plastic container or a gas-impermeable plastic container wrapped in a gas-impermeable film.

[0006] Patent Document 4 discloses a foaming bath agent mainly composed of sodium bicarbonate and / or sodium carbonate and adipic acid. Also disclosed is the effervescent bath agent, in which the molar ratio of sodium bicarbonate and / or sodium carbonate to adipic acid is within the region surrounded by ABCD in FIG.

[0007] Patent Document 5 discloses a weakly acidic bath additive that contains a carbonate and an acid, and is characterized in that the acid is one or more selected from the group consisting of organic acids represented by (Cu) (COOH) (wherein n is an integer of 0 to 6 (except n=2)) and their salts, and that the pi of the bath additive when dissolved in bath water is 4 to 7 (0.01% by weight aqueous solution).

[0008] Patent document 6 describes a liquid dentifrice characterized by the presence of an effective amount of bicarbonate ions in the liquid dentifrice medium. A liquid dentifrice characterized in that an effective amount of bicarbonate ions is present by blending hydrogen carbonate and adjusting the pH of the liquid dentifrice medium to between 7.8 and 9.0. A liquid dentifrice containing a dye, characterized in that an effective amount of bicarbonate ions is present by blending hydrogen carbonate and adjusting the pH of the liquid dentifrice medium to between 7.8 and 9.0. 4. A liquid dentifrice according to claim 2 or claim 3, characterized in that the bicarbonate is sodium bicarbonate. 5. The liquid dentifrice according to claim 1, characterized in that the composition of the liquid dentifrice does not contain citric acid or a salt thereof. 6. The liquid dentifrice according to any one of claims 1 to 5, characterized in that the liquid dentifrice does not contain a parahydroxybenzoic acid ester in its composition. The liquid dentifrice according to any one of claims 1 to 6 is disclosed, characterized in that it contains a flavoring having a phenol group.

[0009] Patent Document 7 discloses an oral solid preparation characterized in that a foaming agent that foams when dissolved in the oral cavity is blended with a substance having an unpleasant taste. [Prior art documents] [Patent documents]

[0010] [Patent Document 1] JP 2013-129654 A [Patent Document 2] JP 2011-105615 A [Patent Document 3] JP 2004-149495 A [Patent Document 4] Japanese Patent Application Publication No. 61-078717 [Patent Document 5] Japanese Patent Application Publication No. 185710 / 1983 [Patent Document 6] Japanese Patent Application Publication No. 10-147511 [Patent Document 7] Japanese Patent Application Publication No. 04-327526 Summary of the Invention [Problem to be solved by the invention]

[0011] There are several challenges to overcome, including the need to avoid foaming as much as possible before use, the need to adjust the raw material mix so that it can be used effectively with the filling machines used in production, and the need to ensure that consumers can see that the product is foaming well when it is being used.

[0012] The present invention has been made in order to solve these problems and address these issues, and aims to provide a nutritional supplement comprising packets of baking soda and citric acid, and a method for producing the same. [Means for solving the problem]

[0013] In order to achieve the above object, the present invention has the following configuration.

[0014] A nutritional supplement in which sodium bicarbonate and citric acid are separated and packaged, The sodium bicarbonate packets are made from selected ingredients that do not contain acid. It is characterized by: This can prevent foaming inside the packet before use.

[0015] The citric acid contained in the sachets is calcium-coated citric acid. It is characterized by: This can prevent foaming inside the packet before use.

[0016] The sodium bicarbonate contained in the sachet is a granular product. A dietary supplement characterized by: This facilitates filling using the filling machine.

[0017] The sachet containing the citric acid was further filled with isomalt granules. A dietary supplement characterized by: This allows the water content to be adjusted.

[0018] The sodium bicarbonate-containing sachet was further supplemented with indigestible dextrin. A dietary supplement characterized by: This allows the water content to be adjusted.

[0019] The sodium bicarbonate sachet contains: Granules of indigestible dextrin, Lemon, a spice Xylitol, Stevia, a sweetener Add The sachets containing citric acid include: Isomalt granules A dietary supplement characterized by the addition of This allows the raw materials to pass smoothly through the filling machine used during production, which is designed to prevent foaming as much as possible before use. The consumer can see that the product is foaming well when it is used. This solved the problem. Effect of the Invention

[0020] Since the present invention is configured as described above, foaming is avoided as much as possible before use, and the raw material can pass smoothly through the filling machine used during production. The consumer can easily see that the product is foaming when it is used. [Brief description of the drawings]

[0021] [Figure 1] This is a diagram showing the first prototype. [Diagram 2] This is a diagram showing the second prototype. [Diagram 3] This is a diagram showing the third prototype. [Figure 4] FIG. 1 is a diagram showing the entire development process. [Diagram 5] FIG. 1 is a diagram showing the initial raw material composition specification table for separate packaging. [Figure 6] This is a diagram showing the second raw material composition specification table for separate packaging. [Figure 7] This is a diagram showing the third raw material composition specification table for separate packaging. [Figure 8] This is a diagram showing the fourth raw material composition specification table for separate packaging. [Figure 9] FIG. 1 is a diagram showing a raw material mixture specification table for the prototype of an actual machine (a filling machine for mass production). DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0022] Hereinafter, an embodiment of the present invention will be described in detail with reference to the drawings.

[0023] <<The process leading up to the first prototype>> (See Figure 1) When citric acid, baking soda, and water are combined, a chemical reaction occurs and the mixture foams up. If the foaming occurs before use, the bag will swell up, which can be a problem. In order to slow down the chemical reactions that occur after the drug is divided into individual doses, the researchers came up with a prototype that uses a coating made from baking soda and citric acid. When used, the coated product was found to produce more foam when dissolved in water than the uncoated product, as was visually observed. Since fluidity is necessary when filling individual packages, using a coated product (granular product) can eliminate the granulation process, providing significant cost benefits. First prototype ●Product Specifications ·5,000mg / packet ●Combination · Dextrin: 700 mg · Sodium bicarbonate (granular product): 1500 mg · Citric acid (coated product): 1500 mg · Flavor: 750 mg · Xylitol: 500 mg · Sweetener (Stevia): 50 mg ● Manufacturing method · Trituration mixing (Thoroughly manage indoor humidity so that the water content of the mixed powder does not increase) · Sub-packaging by hand and conducting an accelerated test (37 - 40 °C) ● Results · The sub-packaging of the accelerated test product begins to slightly expand after about 5 days. · It was found that the reaction can be delayed but not eliminated. · Even in the case of the coated product, it was concluded that it would penetrate after mixing. · Since the water content of the mixed powder cannot be completely eliminated, "baking soda", "citric acid", and "water" will combine.

[0024] ≪Process until the second trial production≫ (See Figure 2) The blending ratios of "baking soda" and "citric acid" were tried in several patterns, but all of them expanded. Meetings were held repeatedly to see if there was any solution. We arrived at the idea of separating "baking soda" and "citric acid". When dividing "baking soda" and "citric acid" into two sub-packages (sub-packaging according to the single-use amount), select raw materials without "acid" in the blending raw materials on the "baking soda" side and divide the blending. Based on the above, the adjustment of "sour taste" and "sweet taste" was also carried out. Second trial production ● Product specifications · 2,750 mg / A (baking soda) sub-package, 2,250 mg / B (citric acid) sub-package ● Blending <A (baking soda) sub-package - 2.75 g / package> · Dextrin: 450 mg · Sodium bicarbonate (granular product): 1500 mg · Xylitol: 500 mg · Sweetener (Stevia): 300 mg <B (Citric acid) sub-pack - 2.25 g / pack> · Citric acid (coated product): 1,000 mg · Citric acid (ordinary product): 500 mg · Flavor: 750 mg ● Manufacturing method · Trituration mixing (strictly manage indoor temperature and humidity to prevent the water content of the mixed powder from increasing) · Sub-pack by hand-packing and conduct accelerated test ● Results · There is no change in both A and B sub-packages of the accelerated test product · As a result of repeatedly adjusting the taste and foaming condition, it reaches 3.5 g for sub-package A and 1.5 g for sub-package B · Considering the taste and foaming condition, change the compound raw materials for each sub-package · Repeatedly conduct test adjustments for verification

[0025] ≪Process until the third trial production≫ (see Figure 3) The problem of sub-package expansion has been solved by separated sub-packing Next, the "taste" during use, the "foaming degree" when adding water during use, and the selection and verification of the "stick filling process" were repeatedly carried out Based on the content of the previous trial production, the formulation was selected and the stick filling test was conducted The third trial production ● Product specifications · 3,500 mg / A (sodium bicarbonate) sub-pack, 1,500 mg / B (citric acid) sub-pack · Stick size: 22 mm × 130 mm / A, 22 mm × 100 mm / B ● Formulation <A (sodium bicarbonate) sub-pack - 3.50 g / pack> · Dextrin: 450 mg · Sodium bicarbonate (granular product): 1500 mg · Flavor: 750 mg · Xylitol: 500 mg · Sweetener (Stevia): 300 mg <B (citric acid) sub-pack - 1.50 g / pack> · Citric acid (coated product): 1,000 mg · Resistant dextrin: 500 mg ● Manufacturing method · Dilution mixing (Strictly manage indoor temperature and humidity to prevent the water content of the mixed powder from increasing) · Stick filling test using the actual machine ● Results · There is no change in both Sub - packs A and B of the accelerated test samples · During stick filling for both A and B, powder adheres to the edge of the filling sliding part mass (the part where powder drops quantitatively) of the machine, and stable filling cannot be achieved · Lowering the water content or using a static eliminator for the filling test did not improve the situation, and it was determined that re - selection of raw materials was necessary · Review the physical properties and formulations of each raw material and repeat the tests many times

[0026] ≪Adjustment of raw material formulation≫ Refer to Figures 4, 5, 6, and 7 In order to avoid the situation where raw materials adhere to the filling sliding part mass during stick filling and stable filling cannot be achieved, the raw material formulations were varied and raw materials were selected

[0027] ≪Process towards the fourth trial production≫ Refer to Figure 8 ◎ Change the dextrin in Sub - pack A to resistant dextrin (granular product) ◎ Also change the fragrance in Sub - pack A to a raw material manufacturer with good fluidity ◎ Change the xylitol in Sub - pack A from the powdered product to the crystalline product ◎ Change the resistant dextrin (granular product) in Sub - pack B to isomalt (granular product) ◎ Adjust the water content of each mixed powder and start the actual machine trial production again Fourth trial production ● Product specifications · 3,500 mg / A (sodium bicarbonate) sub - pack, 1,500 mg / B (citric acid) sub - pack · Stick size: 22 mm × 120 mm / A, 22 mm × 100 mm / B ● Formulation <Sub - pack A (sodium bicarbonate) - 3.50 g / pack> · Resistant dextrin (granular product): 950 mg · Sodium bicarbonate (granular product): 1500 mg · Fragrance: 250 mg · Xylitol (crystalline): 500 mg · Sweetener (Stevia): 300 mg <B (Citric acid) subpackage - 1.50 g / package> · Citric acid (coated): 1,000 mg · Isomalt: 500 mg ● Manufacturing method · Trituration mixing (thoroughly manage indoor temperature and humidity to prevent the water content of the mixed powder from increasing) · Stick filling test using the actual machine ● Results · The accelerated test samples showed no changes in both Subpackage A and Subpackage B · There were no problems in the stick filling process for both A and B

[0028] ≪Process towards the 5th prototype≫ Refer to Figure 9 The stick filling process was cleared while ensuring "taste" and "foaming degree". The stick size was changed for cost review Re - prototype testing was started with the desired stick size 5th prototype ● Product specifications · 3,500 mg / A (sodium bicarbonate) subpackage, 1,500 mg / B (citric acid) subpackage · Stick size: 22 mm × 120 mm / A, 22 mm × 80 mm / B ● Formulation <A (sodium bicarbonate) subpackage - 3.50 g / package> · Resistant dextrin (granular) (Fibersol - 2AG, manufactured by Matsutani Chemical Industry Co., Ltd.): 950 mg · Sodium bicarbonate (granular) (Sodium bicarbonate granules (food additive), manufactured by Iwata Chemical Industry Co., Ltd.): 1,500 mg · Flavor (Lemon Micron D - 911, manufactured by Takasago Perfumery Co., Ltd.): 250 mg · Xylitol (crystalline) (Xylitol fine powder, manufactured by Mitsubishi Corporation Foodtech Co., Ltd.): 500 mg · Sweetener (Stevia) (Enzyme - treated Stevia SK Sweet Z3, manufactured by Nippon Paper Industries Co., Ltd.): 300 mg <B (citric acid) subpackage - 1.50 g / package> Citric acid (coated product) (Iwata Chemical Industry Co., Ltd. Food additive Citric acid (anhydrous) preparation Citric acid CI): 1,000 mg Isomalt (Showa Sangyo Co., Ltd. Isomalt 900P): 500mg ●Manufacturing method - Dilution and mixing (strict indoor temperature and humidity control to prevent the moisture content of the mixed powder from increasing) A stick filling test was carried out using the actual machine (to ensure that the powder does not stick to the filling sliding mass). ●Results · There was no change in the accelerated test products in either package A or B. · No problems with the stick filling process for both A and B. Although the stick size has been reduced, it still passed the filling test.

[0029] Although the embodiment of the present invention has been described above, the embodiment of the present invention is not limited to the above-described embodiment.

Claims

1. A nutritional supplement in which sodium bicarbonate and citric acid are separated and packaged, The sodium bicarbonate packets are made from selected ingredients that do not contain acid. A dietary supplement characterized by:

2. 2. A dietary supplement as claimed in claim 1, comprising: The citric acid contained in the sachets is calcium-coated citric acid. A dietary supplement characterized by:

3. 2. A dietary supplement as claimed in claim 1, comprising: The sodium bicarbonate contained in the sachet is a granular product. A dietary supplement characterized by:

4. 2. A dietary supplement as claimed in claim 1, comprising: The sachet containing the citric acid was further filled with isomalt granules. A dietary supplement characterized by:

5. 2. A dietary supplement as claimed in claim 1, comprising: The sodium bicarbonate-containing sachet was further supplemented with indigestible dextrin. A dietary supplement characterized by:

6. 2. A dietary supplement as claimed in claim 1, comprising: The sodium bicarbonate sachet contains: Granules of indigestible dextrin, Lemon, a spice Xylitol, Stevia, a sweetener Add The sachets containing citric acid include: Isomalt granules A dietary supplement characterized by the addition of

Images